http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102157043-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-867
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742
filingDate 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102157043-B1
titleOfInvention Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using bacillus coagulans sbc37-01, mtcc 5856
abstract The present invention relates to the treatment of diarrhea predominant irritable bowel syndrome in humans comprising oral administration of Bacillus coagulans SBC37-01, MTCC 5856 (containing at least 2 billion spores), with standard treatment of management in a specific manner. It shows the method for management.
priorityDate 2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011204886-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452554217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10959536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578

Total number of triples: 22.